Welcome to the our Aesthetic Medicine news roundup, 4 December 2020.

News

Vitro Biopharma Names World Renown Physician Entrepreneur as its CEO & Retains its Present CEO as CSO.
Vitro Biopharma announced the appointment by its Board of Directors of Jack Zamora, MD as its new Chief Executive Officer (“CEO”) and the retention of Dr. James Musick, the current CEO as Chief Science Officer (“CSO”).


Pandemic has created perfect storm for plastic surgery boom
After logging many hours on Zoom, Sarah Hayes became distressed. “I noticed my face was starting to look older: fine lines and droopy,” said the senior program manager for a financial firm in New Hampshire. “I’m definitely bothered by my lines more on video than in real life.”


From full face filler to the 8 teeth smile: These are going to be the biggest cosmetic tweakment trends of 2021
Whether you have regular tweakments or are simply curious about them, there’s no denying that non-surgical cosmetic procedures like Botox and dermal fillers are becoming increasingly popular, alongside traditional surgeries. And as they infiltrate more people’s beauty regimes, there’s more research into new and improved treatments, which are able to treat a wider variety of conditions and concerns.


AbbVie wins bid to block U.S. imports of a Botox rival
The U.S. International Trade Commission on Wednesday upheld a judge’s finding that competitors made their treatment with a secret process stolen from AbbVie’s South Korean partner.


Latest Global Survey from ISAPS Reports Continuing Rise in Aesthetic Surgery Worldwide
The International Society of Aesthetic Plastic Surgery (ISAPS) released the results of its annual Global Survey on Aesthetic/Cosmetic Procedures today, showing a 7.4% increase in cosmetic procedures completed in 2019.


AMP

Previous articleBrent Saunders Launches Special Purpose Acquisition Company
Next articleAesthetic Medical Practitioner #24